(MedPage Today) -- The FDA finalized clinical guidance for psychedelic drug developers and scheduled a public hearing for September to discuss potential therapeutic uses.
(MedPage Today) -- The FDA finalized clinical guidance for psychedelic drug developers and scheduled a public hearing for September to discuss potential therapeutic uses.